C

    CVRx Inc (CVRX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.96
    +0.01 (+0.34%)

    Market Cap: $78.59M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(12/22)
    Avg Surprise
    -8.97%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.50
    Range$-0.53 - $-0.47
    5 analysts
    EPS Revisions
    3
    0
    7d
    3
    2
    30d
    EPS Estimate Drift
    90d ago$-0.48+5.0%
    60d ago$-0.48+3.7%
    30d ago$-0.48+3.7%
    7d ago$-0.48+3.7%
    Current$-0.50
    Revenue Consensus
    $14M
    Range$14M - $14M
    6 analysts
    Dec 31, 2026
    EPS Consensus$-0.49
    Range$-0.53 - $-0.42
    5 analysts
    Revenue Consensus
    $15M
    Range$14M - $15M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.49---
    Sep 26EST
    		-$-0.50---
    Jun 26
    		$-0.53$-0.52-1.92%Miss+7.0%
    Mar 26
    		$-0.50$-0.50+0.00%Beat+5.7%
    Dec 25
    		$-0.46$-0.44-4.55%Miss-7.0%
    Sep 25
    		$-0.49$-0.50+2.00%Beat+14.0%
    Jun 25
    		$-0.57$-0.52-9.62%Miss+12.3%
    Mar 25
    		$-0.53$-0.57+7.02%Beat+49.0%
    Dec 24
    		$-0.43$-0.38-13.16%Miss+2.3%
    Sep 24
    		$-0.57$-0.47-21.28%Miss-32.6%
    Jun 24
    		$-0.65$-0.55-18.18%Miss-16.1%
    Mar 24
    		$-1.04$-0.54-92.59%Miss-89.1%
    Dec 23
    		$-0.44$-0.55+20.00%Beat+13.7%
    Sep 23
    		$-0.43$-0.58+25.86%Beat+10.4%
    Jun 23
    		$-0.56$-0.58+3.45%Beat-3.7%
    Mar 23
    		$-0.55$-0.57+3.51%Beat-12.2%
    Dec 22
    		$-0.51$-0.56+8.93%Beat+1.9%
    Sep 22
    		$-0.48$-0.56+14.29%Beat-60.0%
    Jun 22
    		$-0.54$-0.53-1.89%Miss+98.9%
    Mar 22
    		$-0.49$-0.49+0.00%Beat+30.0%
    Dec 21
    		$-0.52$-0.44-18.18%Miss+14.0%
    Sep 21
    		$-0.30$-0.40+25.00%Beat-45.8%
    Jun 21
    		$-48.48$-21.45-126.01%Miss-
    Mar 21
    		$-0.70$-0.70+0.00%Beat-
    Dec 20
    		$-0.60$0.00N/AMiss-
    Dec 19
    		$-0.21$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.49EV/EBITDA-1.31x
    Price/FCF-1.91xFCF Yield-52.31%
    Profitability
    Profit Margin-84.90%Operating Margin-82.90%
    ROE-133.50%ROIC-58.51%
    Financial Health
    Debt/Equity2.94xInterest Coverage-7.62x
    Current Ratio8.04xQuick Ratio6.87x
    Trading Statistics
    Beta0.82Avg Volume1.64M
    52-Week High$11.3052-Week Low$2.20

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.00
    SMA 20$3.29
    SMA 50$4.46
    SMA 200$6.63
    EMA 10$3.08
    EMA 20$3.38
    EMA 50$4.23
    EMA 200$6.23

    MACD

    Line: -0.45Signal: -0.52Hist: 0.07

    ADX

    ADX: 20.6+DI: 22.7-DI: 34.1

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down40.0
    PSAR$4.22

    Bollinger Bands

    Upper Band$5.41
    Lower Band$1.18
    %B Position12844%(Upper)
    Band Width0.42

    RSI (14-Day)

    Neutral
    38.7

    Momentum Oscillators

    Stoch %K58.8
    Stoch %D64.2
    Williams %R-50.0
    ROC (10d)7.6%
    Momentum0.21
    CCI (20d)-35.3
    MFI (14d)64.4

    Volatility Measures

    ATR (14d)$0.36(12.0%)
    StdDev (20d)1.06
    Hist Vol234.2%(High)

    Volume Flow

    VWAP$2.92
    OBV-6.0M
    AD Line-7.9M
    CMF (20d)-0.163

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio0.4x(Low)
    VWMA (20d)$2.73

    Pivot Points

    R3$3.30
    R2$3.22
    R1$3.09
    Pivot Point$3.01
    S1$2.88
    S2$2.80
    S3$2.67

    Advanced Oscillators

    TSI-24.43
    Ultimate Osc47.3
    KST-366.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$15.71M$14.77M$16.02M$14.69M$13.59M$12.35M$15.34M$13.37M$11.81M$10.77M$11.30M$10.51M
    Cost of Revenue$1.98M$1.89M$2.20M$1.94M$2.14M$2.04M$2.57M$2.25M$1.90M$1.61M$1.72M$1.69M
    Gross Profit$13.72M$12.88M$13.82M$12.75M$11.45M$10.31M$12.77M$11.13M$9.91M$9.15M$9.59M$8.82M
    Operating Expenses$26.75M$25.04M$25.01M$25.02M$25.83M$23.75M$23.05M$24.14M$23.88M$31.39M$19.25M$18.35M
    R&D$3.13M$3.08M$3.00M$3.15M$2.47M$2.52M$2.81M$2.50M$2.77M$3.06M$2.24M$2.70M
    SG&A$23.62M$21.96M$22.01M$21.88M$23.36M$21.23M$20.24M$21.63M$21.11M$28.33M$17.00M$15.65M
    Operating Income$-13,023,000$-12,161,000$-11,184,000$-12,268,000$-14,376,000$-13,437,000$-10,274,000$-13,011,000$-13,973,000$-22,232,000$-9,661,000$-9,528,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.58M$1.55M$1.42M$1.48M$1.47M$1.46M$1.52M$958,000$959,000$960,000$579,000$499,000
    Income Before Tax$-14,041,000$-13,119,000$-11,941,000$-12,873,000$-14,739,000$-13,771,000$-10,722,000$-13,052,000$-13,988,000$-22,148,000$-9,124,000$-8,971,000
    Income Tax Expense$3,000$1,000$-7,000$-3,000$-3,000$-5,000$-71,000$47,000$41,000$38,000$39,000$40,000
    Net Income$-14,044,000$-13,120,000$-11,934,000$-12,870,000$-14,736,000$-13,766,000$-10,651,000$-13,099,000$-14,029,000$-22,186,000$-9,163,000$-9,011,000
    EBITDA$-12,170,000$-11,280,000$-10,278,000$-11,138,000$-13,013,000$-12,071,000$-8,963,000$-11,880,000$-12,839,000$-21,009,000$-8,376,000$-8,294,000
    EBIT$-12,463,000$-11,568,000$-10,524,000$-11,393,000$-13,266,000$-12,314,000$-9,202,000$-12,094,000$-13,029,000$-21,188,000$-8,545,000$-8,472,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CVRX

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Jorey Chernett Pushes for Sale at CVRx with 5.5% Stake

    Jorey Chernett has disclosed a 5.5% stake in CVRx, Inc. and is actively pushing for the company to initiate a sale process. He sent a letter to the board on August 24, 2026, urging them to retain an independent financial advisor and conduct a full review of strategic options, with a sale as the primary goal. Chernett, a private investor, aims to unlock value in what he views as an undervalued situation.

    TradingView•8/25/26•
    Somewhat-Bearish

    Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)

    CVRx (CVRX) has entered oversold territory after a 31.7% drop in the past four weeks, indicated by its Relative Strength Index (RSI) of 29.38. This technical signal, combined with a 0.9% increase in consensus EPS estimates from analysts over the last 30 days and a Zacks Rank #2 (Buy), suggests a potential rebound. Investors might find this an opportune moment to consider the stock due to the exhaustion of selling pressure and improving fundamental outlook.

    qz.com•8/25/26•
    Bullish

    CVRx Responds to Letter from Pointillist Family Office

    CVRx, Inc. issued a statement in response to a public letter from Pointillist Family Office, affirming its commitment to shareholder interests. The company acknowledges that its Barostim therapy is highly differentiated and that its current valuation does not fully reflect its potential. CVRx expressed confidence in its business fundamentals and strategies to drive Barostim growth while managing expenses, and remains open to constructive engagement with shareholders.

    The Manila Times•8/25/26•
    Somewhat-Bullish

    CVRx has an activist investor urging it to get acquired

    An activist investor, Pointillist Family Office founder Jorey Chernett, is pressuring CVRx to sell the company to a larger strategic acquirer. Chernett, who owns 5.5% of CVRx, believes that a larger medical device company could better capitalize on the Barostim system's value due to established sales organizations, payer relationships, and financial resources. This push comes after a disappointing second-quarter report and a DOJ civil investigation, causing CVRX shares to drop, although they recently gained 18% following Chernett's call for a sale.

    MassDevice•8/25/26•
    Somewhat-Bearish

    3 Penny Stocks With At Least $70M Market Cap

    This article identifies three penny stocks—AlTi Global (ALTI), CVRx (CVRX), and OPKO Health (OPK)—that possess a market capitalization of at least $70 million and strong financial health despite varying profitability statuses. It highlights their current financial positions, recent developments, and future outlooks, emphasizing the importance of underlying financials for growth potential in "penny stocks."

    Simply Wall Street•8/25/26•
    Neutral

    Frequently Asked Questions About CVRX

    Does CVRX pay dividends?
    CVRx Inc (CVRX) does not currently pay a regular dividend.
    What is CVRX's market cap?
    CVRx Inc (CVRX) has a market capitalization of $78.59M with a current stock price of $2.96.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In